BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10777845)

  • 1. Evaluation of prognostic factors and PCNA expression for pulmonary metastatic tumors of colorectal carcinoma.
    Matsushima S; Yamamoto H; Suzuki S; Egami K; Yoshioka M; Yamada N; Tanaka S
    J Nippon Med Sch; 2000 Feb; 67(1):28-31. PubMed ID: 10777845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of proliferating cell nuclear antigen and CD44 variant isoforms in the primary and metastatic sites of nonsmall cell lung carcinoma with intrapulmonary metastases.
    Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
    Cancer; 1999 Oct; 86(7):1174-81. PubMed ID: 10506701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.
    Hiraga Y; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F; Kohno N
    Oncology; 1998; 55(4):307-19. PubMed ID: 9663420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor expression in metastatic pulmonary tumor from colorectal carcinoma: utility as a prognostic factor.
    Tamura M; Oda M; Tsunezuka Y; Matsumoto I; Kawakami K; Watanabe G
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):517-22. PubMed ID: 15457151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of proliferating cell nuclear antigen expression and prognosis in patients with renal cell carcinoma with pulmonary metastases.
    Gotoh A; Hanioka K; Shirakawa T; Wada Y; Gohji K; Okada H; Arakawa S; Kamidono S
    Int J Urol; 1998 May; 5(3):214-8. PubMed ID: 9624550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas.
    Choi HJ; Jung IK; Kim SS; Hong SH
    Dis Colon Rectum; 1997 Jan; 40(1):51-9. PubMed ID: 9102262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
    Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
    Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and immunohistochemical analyses in lung metastasis of colorectal carcinoma.
    Koshiji M; Ogura E; Takada H; Kawanishi H; Ikehara S; Hioki K
    Oncol Rep; 1998; 5(4):811-5. PubMed ID: 9625823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histopathologic prognostic factors in resected colorectal lung metastases.
    Shiono S; Ishii G; Nagai K; Yoshida J; Nishimura M; Murata Y; Tsuta K; Nishiwaki Y; Kodama T; Ochiai A
    Ann Thorac Surg; 2005 Jan; 79(1):278-82; discussion 283. PubMed ID: 15620957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma.
    Tanaka S; Haruma K; Tatsuta S; Hiraga Y; Teixeira CR; Shimamoto F; Yoshihara M; Sumii K; Kajiyama G
    Oncology; 1995; 52(2):134-9. PubMed ID: 7854773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term Survival of Patients with Lung Metastases from Colorectal and Non-colorectal Cancer Who Underwent Pulmonary Metastasectomy.
    Lumachi F; Mazza F; Del Conte A; Lo Re G; Ermani M; Chiara GB; Basso SM
    Anticancer Res; 2015 Jun; 35(6):3563-6. PubMed ID: 26026126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of proliferating cell nuclear antigen (PCNA) expression in 24 cases of primary non-small cell pulmonary carcinomas and correlation with survival].
    Castellano VM; Sotelo T; Ballestín C; López-Encuentra A; Varela G
    Arch Bronconeumol; 1996 Mar; 32(3):127-31. PubMed ID: 8634790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases.
    Fukuse T; Hirata T; Naiki H; Hitomi S; Wada H
    Ann Surg; 2000 Jul; 232(1):112-8. PubMed ID: 10862203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proliferating cell nuclear antigen (PCNA) in ovarian carcinoma and its relation to lymph node metastasis and prognosis].
    Wu X; Zhang Z; Cai S
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):68-70. PubMed ID: 10921065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer.
    Nakae S; Nakamura T; Ikegawa R; Yoshioka H; Shirono J; Tabuchi Y
    J Surg Oncol; 1998 Sep; 69(1):28-35. PubMed ID: 9762888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors affecting the surgical treatment of metastatic lung tumor from colorectal cancer].
    Otani Y; Shomura H; Aiyama T; Funai T; Tsuji T; Orimo T; Shonaka T; Shibaki T; Yanagida N; Inagaki M; Akabane H; Nakano S
    Kyobu Geka; 2013 Apr; 66(4):279-83. PubMed ID: 23575178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.
    Zhang JC; Wang ZR; Cheng YJ; Yang DZ; Shi JS; Liang AL; Liu NN; Wang XM
    World J Gastroenterol; 2003 Jul; 9(7):1482-6. PubMed ID: 12854146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic tumor doubling time is an independent predictor of intrapulmonary recurrence after pulmonary resection of solitary pulmonary metastasis from colorectal cancer.
    Tomimaru Y; Noura S; Ohue M; Okami J; Oda K; Higashiyama M; Yamada T; Miyashiro I; Ohigashi H; Yano M; Kodama K; Ishikawa O; Murata K; Yokouchi H; Sasaki Y; Kameyama M; Imaoka S
    Dig Surg; 2008; 25(3):220-5. PubMed ID: 18577868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proliferating cell nuclear antigen and p53 protein expression in submucosal invasive colorectal carcinoma].
    Kanazawa Y; Onda M; Tanaka N; Seya T
    J Nippon Med Sch; 2000 Aug; 67(4):242-9. PubMed ID: 10938592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2,p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma.
    Sun XF; Carstensen JM; Stål O; Zhang H; Nordenskjöld B
    Int J Cancer; 1996 Feb; 69(1):5-8. PubMed ID: 8600060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.